Published in PLoS One on December 03, 2010
Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis (2012) 1.08
Mutations in AQP5, encoding a water-channel protein, cause autosomal-dominant diffuse nonepidermolytic palmoplantar keratoderma. Am J Hum Genet (2013) 0.94
Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum Genet (2012) 0.88
Aquaporin 5 regulates cigarette smoke induced emphysema by modulating barrier and immune properties of the epithelium. Tissue Barriers (2013) 0.87
Critical role of aquaporins in interleukin 1β (IL-1β)-induced inflammation. J Biol Chem (2014) 0.81
Water permeability of the mammalian cochlea: functional features of an aquaporin-facilitated water shunt at the perilymph-endolymph barrier. Pflugers Arch (2014) 0.80
Physiological role of aquaporin 5 in salivary glands. Pflugers Arch (2015) 0.78
Genetic variants of CDH13 determine the susceptibility to chronic obstructive pulmonary disease in a Chinese population. Acta Pharmacol Sin (2016) 0.77
Expression of aquaporins in bronchial tissue and lung parenchyma of patients with chronic obstructive pulmonary disease. Multidiscip Respir Med (2014) 0.75
Effect of Abnormal Savda Munziq, a Traditional Uighur Herbal Medicine, on Pulmonary Function and Aquaporins of COPD Rat Model with Abnormal Savda Syndrome. Evid Based Complement Alternat Med (2017) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
The structure of haplotype blocks in the human genome. Science (2002) 50.88
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet (2004) 5.16
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. Respir Care (2002) 3.02
TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax (2000) 2.14
Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med (1996) 1.96
Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: A meta-analysis. Respirology (2010) 1.63
Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA (2008) 1.51
Aquaporin water channels and lung physiology. Am J Physiol Lung Cell Mol Physiol (2000) 1.50
Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease. Control Clin Trials (1993) 1.43
The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses (2004) 1.42
Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients. Lab Invest (2001) 1.40
Aquaporin 5-deficient mouse lungs are hyperresponsive to cholinergic stimulation. Proc Natl Acad Sci U S A (2001) 1.35
Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax (2002) 1.31
Shear stress regulates aquaporin-5 and airway epithelial barrier function. Proc Natl Acad Sci U S A (2008) 1.22
CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet (2001) 1.22
Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med (2004) 1.19
cAMP has distinct acute and chronic effects on aquaporin-5 in lung epithelial cells. J Biol Chem (2004) 1.17
Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics (1991) 1.11
The human Aquaporin-5 gene. Molecular characterization and chromosomal localization. J Biol Chem (1996) 1.00
Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J (2009) 1.00
Lung Health Study. Am Rev Respir Dis (1989) 0.99
Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease. Acta Pharmacol Sin (2007) 0.98
Transforming growth factor-beta1 polymorphisms, airway responsiveness and lung function decline in smokers. Respir Med (2006) 0.92
Cigarette smoke extract inhibits expression of peroxiredoxin V and increases airway epithelial permeability. Inhal Toxicol (2006) 0.90
Role of aquaporin 5 in antigen-induced airway inflammation and mucous hyperproduction in mice. J Cell Mol Med (2010) 0.89
Interferon gamma polymorphisms and their interaction with smoking are associated with lung function. Hum Genet (2006) 0.89
Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells. Respir Med (2005) 0.88
Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis. COPD (2010) 0.86
Altered regulation of aquaporin gene expression in allergen and IL-13-induced mouse models of asthma. Cytokine (2009) 0.85
Interactive effect of paraoxonase-1 Q192R polymorphism and smoking history on the lung function decline in grain workers. Ann Epidemiol (2008) 0.84
Polymorphisms of aquaporin5 gene in chronic obstructive pulmonary disease in a Chinese population. Swiss Med Wkly (2008) 0.82
The genetic association database. Nat Genet (2004) 11.29
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med (2005) 8.86
Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet (2011) 8.57
Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67
Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet (2009) 6.36
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet (2012) 5.48
Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet (2011) 5.41
Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40
Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med (2002) 4.27
The PhenX Toolkit: get the most from your measures. Am J Epidemiol (2011) 4.19
Variants of DENND1B associated with asthma in children. N Engl J Med (2009) 4.18
Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med (2002) 4.11
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98
Aquaporin water channels--from atomic structure to clinical medicine. J Physiol (2002) 3.70
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol (2010) 3.48
Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44
Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet (2009) 3.41
Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA (2012) 3.40
A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet (2008) 3.25
The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 3.24
Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med (2004) 3.19
Genetics and epidemiology. Curr Opin Allergy Clin Immunol (2002) 3.12
CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest (2009) 2.96
Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.82
Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol (2007) 2.79
Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32-35. Am J Hum Genet (2004) 2.65
Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med (2011) 2.64
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med (2008) 2.64
Maternal vitamin A supplementation and lung function in offspring. N Engl J Med (2010) 2.61
Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int (2009) 2.53
A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol (2009) 2.53
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol (2009) 2.20
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
The FaceBase Consortium: a comprehensive program to facilitate craniofacial research. Dev Biol (2011) 2.16
Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci. Nat Genet (2012) 2.15
Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet (2012) 2.14
Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Int J Radiat Oncol Biol Phys (2006) 2.11
Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci U S A (2008) 2.10
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes (2011) 2.09
Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.09
The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol (2008) 2.08
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax (2007) 2.05
Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med (2003) 2.03
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol (2009) 2.00
The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet (2002) 1.99
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98
The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS (2013) 1.92
Alcohol volume, drinking pattern, and cardiovascular disease morbidity and mortality: is there a U-shaped function? Am J Epidemiol (2002) 1.91
Body mass index and the risk of COPD. Chest (2002) 1.91
Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol (2006) 1.88
Paradoxical physical findings described by Kussmaul: pulsus paradoxus and Kussmaul's sign. Lancet (2002) 1.85
Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med (2014) 1.80
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest (2007) 1.79
Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol (2010) 1.77
Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med (2002) 1.76
Association between IRF6 and nonsyndromic cleft lip with or without cleft palate in four populations. Genet Med (2007) 1.75
A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. Am J Respir Crit Care Med (2012) 1.74
Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol (2006) 1.73
Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data. BMJ (2011) 1.73
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.72
Adiponectin concentrations: a genome-wide association study. Am J Hum Genet (2010) 1.70
Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol (2011) 1.69
Innate and acquired resistance to amebiasis in bangladeshi children. J Infect Dis (2002) 1.68
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med (2005) 1.67
Acute lung injury review. Intern Med (2009) 1.67
Recombination rates in admixed individuals identified by ancestry-based inference. Nat Genet (2011) 1.64